Detalhe da pesquisa
1.
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Gastroenterology
; 151(6): 1113-1121, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27528177
2.
Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis.
Gastroenterology
; 148(4): 740-750.e2, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25644096
3.
Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial.
J Clin Gastroenterol
; 50(4): 318-25, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26368296
4.
Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
Dig Dis Sci
; 61(1): 221-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26563167
5.
Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.
Dig Dis Sci
; 60(11): 3408-17, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26386854
6.
Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.
Pain Pract
; 15(6): 564-71, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24815199
7.
Rifaximin therapy for patients with irritable bowel syndrome without constipation.
N Engl J Med
; 364(1): 22-32, 2011 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21208106
8.
Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy.
Clin Gastroenterol Hepatol
; 12(8): 1390-7.e2, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24365449
9.
Determination of Optimal Eosinophil Thresholds for Diagnosis of Eosinophilic Gastritis and Duodenitis: A Pooled Analysis of 4 Prospective Studies.
Clin Transl Gastroenterol
; 15(1): e00656, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870521
10.
Rifaximin treatment in hepatic encephalopathy.
N Engl J Med
; 362(12): 1071-81, 2010 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20335583
11.
Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study.
HIV Clin Trials
; 14(6): 261-73, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24334179
12.
Development of a new travellers' diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy.
J Travel Med
; 30(6)2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052453
13.
Nalbuphine Tablets for Cough in Patients with Idiopathic Pulmonary Fibrosis.
NEJM Evid
; 2(8): EVIDoa2300083, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320144
14.
Efficacy and Safety of Naloxegol in Patients with Chronic Non-Cancer Pain Who Experience Opioid-Induced Constipation: A Pooled Analysis of Two Global, Randomized Controlled Studies.
J Pain Res
; 16: 2943-2953, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664485
15.
Safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind study.
J Pediatr Gastroenterol Nutr
; 49(5): 571-9, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19633577
16.
Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.
J Crohns Colitis
; 11(7): 785-791, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28333362
17.
Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors.
Postgrad Med
; 128(3): 273-81, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26861051
18.
Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain.
J Pain Res
; 8: 771-80, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26586963
19.
Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.
PLoS One
; 10(5): e0126438, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25970536
20.
A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
Neuro Oncol
; 5(2): 79-88, 2003 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-12672279